United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 713,700 | 603,400 | 441,600 | 235,500 | 651,600 |
| Depreciation Amortization | 31,600 | 23,800 | 15,600 | 7,700 | 32,900 |
| Accounts receivable | -21,700 | -31,700 | -45,300 | -2,000 | -30,500 |
| Accounts payable and accrued liabilities | 600 | 13,900 | 19,800 | 500 | 17,000 |
| Other Working Capital | -117,400 | -51,700 | -60,600 | 30,400 | -202,100 |
| Other Operating Activity | 36,800 | -77,500 | -119,600 | -146,300 | -86,100 |
| Operating Cash Flow | $643,600 | $480,200 | $251,500 | $125,800 | $382,800 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 129,600 | 78,000 | 48,800 | 21,000 | 257,600 |
| PPE Investments | -38,000 | -23,300 | -14,200 | -3,800 | -49,800 |
| Net Acquisitions | -5,200 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -38,100 | -9,700 | -9,700 | N/A | -54,200 |
| Purchase Sale Intangibles | N/A | -5,200 | -5,200 | -5,200 | 350,000 |
| Other Investing Activity | 0 | -5,200 | -5,200 | -5,200 | 350,000 |
| Investing Cash Flow | $48,300 | $39,800 | $19,700 | $12,000 | $503,600 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -8,800 | -8,800 | -7,900 | -100 | -133,200 |
| Common Stock Issued | 12,000 | 10,500 | 7,200 | 4,800 | 43,300 |
| Common Stock Repurchased | -500,000 | -395,500 | -259,700 | -123,200 | -394,500 |
| Other Financing Activity | -900 | -2,200 | -3,300 | -4,700 | 37,400 |
| Financing Cash Flow | $-497,700 | $-396,000 | $-263,700 | $-123,200 | $-447,000 |
| Exchange Rate Effect | -3,000 | -2,800 | -1,800 | 400 | -5,300 |
| Beginning Cash Position | 831,800 | 831,800 | 831,800 | 831,800 | 397,700 |
| End Cash Position | 1,023,000 | 953,000 | 837,500 | 846,800 | 831,800 |
| Net Cash Flow | $191,200 | $121,200 | $5,700 | $15,000 | $434,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 643,600 | 480,200 | 251,500 | 125,800 | 382,800 |
| Capital Expenditure | -38,000 | -23,300 | -14,200 | -3,800 | -49,800 |
| Free Cash Flow | 605,600 | 456,900 | 237,300 | 122,000 | 333,000 |